Impaired cyclic AMP (cAMP)/PKA signaling and decreased p-CREB were observed in the brains of AD patients [26], whereas treatments that increase CREB activity could alleviate the spatial memory deficits in AD transgenic mice [20]. This evidence concerns the gene CREB1 and Alzheimer disease.